Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2020 Jul 1.

Published in final edited form as: Hepatology. 2019 May 17;70(1):334–345. doi: 10.1002/hep.30624

TABLE 2.

Outcomes of the Patient Cohort Within 7, 14 and 21 Days of Waitlist Registration

	Status 1a				ACLF-3
Total population	7 days	14 days	21 days	P^*	7 days	14 days	21 days	P^*

Survived without	1,001 (29.6)	855 (25.3)	825 (24.4)	0.001	2,432 (47.7)	1,334 (26.1)	858 (16.8)	<0.001
transplantation, n (%)
Transplanted, n (%)	1,771 (52.4)	1,870 (55.3)	1,882 (55.7)	0.001	1,748 (34.3)	2,349 (46.1)	2,573 (50.5)	<0.001
Died/removed, n (%)	605 (17.9)	652 (19.3)	670 (19.8)	0.709	919 (18.0)	1,416 (27.7)	1,668 (32.7)	<0.001

^*

P values represent significance of trend, evaluated by a Wilcoxon-type trend test.